Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commercialization admin April 4, 2018 PR You Might Also Like If pharma looks slow to adopt AI, it’s got good reason, expert says May 2, 2019 The bio-tech industry has been identified as an economic growth in Israel May 20, 2019 Israel On Quest For Digital Health Domination April 11, 2018
